Project Scope Changes. It is the nature of development programs that targets can change. Should NEOGENIX request Selexis complete work outside of the work described in this proposal, and should this change be reasonably deemed significant, written approval (e-mail or fax) will be required prior to initiation, such approval not to be unreasonably withheld or delayed. This additional work could impact the pricing of the project, and in such case, the parties will negotiate in good faith a reasonable price adjustment. Date: August 12, 2009 30 of 37 Neogenix Oncology, Inc. (Page numbering exclusive of Commercial License Agreement – Exhibit B) Selexis SA
Appears in 1 contract
Project Scope Changes. It is the nature of development programs that targets can change. Should NEOGENIX request Selexis complete work outside of the work described in this proposal, and should this change be reasonably deemed significant, written approval (e-mail or fax) will be required prior to initiation, such approval not to be unreasonably withheld or delayed. This additional work could impact the pricing of the project, and in such case, the parties will negotiate in good faith a reasonable price adjustment. Date: August 12, 2009 30 32 of 37 39 Neogenix Oncology, Inc. (Page numbering exclusive of Commercial License Agreement – Exhibit B) Selexis SA
Appears in 1 contract
Project Scope Changes. It is the nature of development programs that targets can change. Should NEOGENIX request Selexis complete work outside of the work described in this proposal, and should this change be reasonably deemed significant, written approval (e-mail or fax) will be required prior to initiation, such approval not to be unreasonably withheld or delayed. This additional work could impact the pricing of the project, and in such case, the parties will negotiate in good faith a reasonable price adjustment. Date: August April 12, 2009 30 2010 32 of 37 39 Neogenix Oncology, Inc. (Page numbering exclusive of Commercial License Agreement – Exhibit B) Selexis SA
Appears in 1 contract
Project Scope Changes. It is the nature of development programs that targets can change. Should NEOGENIX request Selexis complete work outside of the work described in this proposal, and should this change be reasonably deemed significant, written approval (e-mail or fax) will be required prior to initiation, such approval not to be unreasonably withheld or delayed. This additional work could impact the pricing of the project, and in such case, the parties will negotiate in good faith a reasonable price adjustment. Date: August April 12, 2009 30 2010 32 of 37 39 Neogenix Oncology, Inc. (Page numbering exclusive of Commercial License Agreement – Exhibit B) Selexis SASA CONFIDENTIAL H16C3 Project
Appears in 1 contract